medigraphic.com
ISSN 0188-9796 (Impreso)

2006, Número 3

<< Anterior Siguiente >>

Rev Endocrinol Nutr 2006; 14 (3)


Los síntomas en la menopausia

Canto de Cetina T

Idioma: Español
Referencias bibliográficas: 62
Paginas: 141-148
Archivo PDF: 92.37 Kb.


FRAGMENTO

No hay duda de que los síntomas en la menopausia constituyen un importante problema para las mujeres maduras, pero aún no hay criterios uniformes para considerar cuáles son propios de ella o bien resultan del envejecimiento, el deterioro de la salud, factores psicosociales o del estilo de vida. Algunos autores consideran que los únicos síntomas verdaderamente propios de la menopausia son los vasomotores y los relacionados con la vaginitis atrófica, pues son los únicos síntomas asociados directamente con la ooforectomía que presentan alivio con estrógenos.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Holte A. Influences of natural menopause on health complains. A study gof healthy Norwegian women. Maturitas 1992; 14: 127-41

  2. Chim H, Tan BHI, Ang CC, Chew EMD, Chong YS, Saw SM. The prevalence of menopausal symptoms in a community in Singapore. Maturitas 2002; 41: 275-82.

  3. Oddens BJ, Boulet MJ, Lether P, Visser AP. Has the climacteric been medicalised? A study on the use of medication for climacteric complaints in four countries. Maturitas 1992; 15; 171-81.

  4. Pan H-A, Wu M-H, Hsu C-C. The perception of menopause among women in Taiwan. Maturitas 2002; 41: 269-74.

  5. Soules MR, Sherman S, Parrott T. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001; 76:874-78.

  6. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000; 96: 351-8.

  7. McKinlay S, Brambilla D, Posner JG. The normal menopause transition. Maturitas 1992; 14: 103-15.

  8. Avis NE, Brockwell S, Colvin A. A universal menopausal syndrome? Am J Med 2005; 118: 37S46S.

  9. Avis NE, Stellato R, Crawford S. Is there a menopausal syndrome? menopausal status and symptoms across ethnic groups. Soc Sci Med 2001; 52: 34.

  10. Fugate NW, Sullivan EM. Symptoms during the perimenopause: prevalence, severity, trajectory and significance in women’s lives. Am J Med 2005; 118: 14S-24S.

  11. Ho SC, Chan SG, Yip YB, Cheng A, Yi Q, Chan C. Menopausal symptoms and symptom clustering in Chinese women. Maturitas 1999; 33: 219-27

  12. Haines CJ, Yim SF, Chung TKH. A prospective, randomized, placebo-controlled study of the dose effect of oral oestradiol on menopausal symptoms, psychological well being, and quality of life in postmenopausal Chinese women. Maturitas 2003; 44: 207-14.

  13. Haines CJ, Rong L, Chung TKH, Leung DHY. The perception of the menopause and the climacteric among women in Hong Kong and Southern China. Prev Med 1995; 24: 245-8.

  14. Lam PM, Leung TN, Haines C, Chung TKH. Climacteric symptoms and knowledge about hormone replacement therapy among Hong Kong Chinese women aged 40-60 years. Maturitas 2003; 45: 99-107.

  15. Haines CJ, Shu-Min Xing, Ki-Hyun Park, Holinka CF, Ausmanas MK. Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated estrogens /medroxyprogesterone acetate: The Pan-Asia menopause (PAM) study. Maturitas 2005; 52: 264-76.

  16. Ming-Huei Cheng, Shuu-Jiun Wang, Peng-Hui Wang, Jong-Ling Fuh. Attitudes toward menopause among middleaged women. A community survey in an island of Taiwan. Maturitas 2005; 52: 348-355.

  17. Fuh JL, Wang SJ, Lu SR, Juang KD, Chiu LM. The kinmen women-health investigation (KIWI). A menopausal study of a population age 40-54. Maturitas 2001; 39: 117-24.

  18. Dhillon K, Singh J, Shuib R, Hamid M, Zaki N. Prevalence of menopausal symptoms in women in Kelantan, Malaysia. The European Menopause Journal 2005.

  19. Flint M. The menopause: reward or punishment? Psychosomatics 1975; 6: 161-63.

  20. Lock M. Ambiguities of aging: Japanese experience and perceptions of menopause. Cult Med Psychiatry 1986; 10: 23-46

  21. Avis NE, Kaufert PA, Lock M, McKinlay SM, Vass K. The evolution of menopausal symptoms. Clin Endocrinol Metab 1993; 7: 17-31.

  22. Canto T, Canto P, Polanco L. Encuesta de síntomas de climaterio en áreas semirurales de Yucatán. Rev Inves Clin 1998; 50: 133-5.

  23. Malacara JM, Canto de CT, Bassol S, González N, Cacique L, Vera-Ramírez ML, Nava LE. Symptoms at pre-and postmenopause in rural and urban women from three States of Mexico. Maturitas 2002; 43: 11-19.

  24. Michel JL, Mahady GB, Veliz M, Soejarto DD, Caceres A. Symptoms, attitudes choices surrounding menopause among the Q’epchi Maya of Livingston, Guatemala. Social Science Medicine 2006. In press.

  25. Martin MC, Block JE, Sánchez SD, Arnaud CD, Beyene Y. Menopause without symptoms: The endocrinology of menopause among rural Mayan Indians. Am J Obstet Gynecol 1993; 168: 1839-46.

  26. Beyene Y. Cultural significance and physiological manifestations of menopause a biocultural analysis. Culture, Medicine and Psychiatry 1986; 10: 47-71.

  27. Avis NE, Crawford SL, McKinlay SM. Psychosocial, behavioral, and health factors related to menopause symptomatology. Womens Health 1997; 3: 103-120

  28. Feldman BM, Voda A, Groseth E. The prevalence of hot flash and associated variables among perimenopausal women. Res Nurs Heath 1985; 8: 261-268.

  29. Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci 1990; 592: 52-86.

  30. Freedman RR, Norton D, Woodward S, Cornelissen G. Core body temperature and cyrcadian rhytm of hot flashes in menopausal women. J Clin Endocrinol Metab 1995; 80: 2354-8.

  31. Freedman R. Physiology of hot flushes. Am J Human Biol 2001; 13: 453-64.

  32. Porter M, Penney GC, Russell D, Russell E, Templeton A. A population based survey of women’s experience of the menopause. Br J Obstet Gynaecol 1996; 103: 1025-8.

  33. Belchetz PE. Hormonal treatment of postmenopausal women. N Engl J Med 1994; 330: 1062-71.

  34. Whiteman MK, Catherine A, Langerberg PW, McCarter RJ, Kjrulff KH, Flaws JA. Smoking, body mass, and hot flashes in midlife women. Obstet Gynecol 2003; 101: 264-72.

  35. Gold EB, Sternfeld B, Kelsey JL, Brown C, Mouton C, Reame N. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000; 152: 463-473. 36. Jessen AB, Toubro S, Astrup A. Effect of chewing gum containing nicotina and caffeine on energy expenditure and substrate utilization in men. Am J Clin Nutr 2002; 77: 1442-47.

  36. Savage MV; Brengelmann GL. Control of skin blood flow in the neutral zone of human body temperature regulation. J Appl Physiol 1996; 80: 1249-57.

  37. Bungay GT, Vessey MP, McPherson CK. Study of symptoms in middle life with special reference to the menopause. BMJ 1980; 19: 181-183.

  38. Hunter M, Battersby R. Whitehead M. Relationships between psychological symptoms, somatic complaints and menopausal status. Maturitas 1986; 8: 217-228.

  39. Freedman RR, Roehrs TA. Lack of sleep disturbance from menopausal hot flashes. Fertil Steril 2004; 82: 138-44.

  40. Young T, Rabago D, Zgierska A, Austin D, Finn L. Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin cohort study. Sleep 2003; 26: 667-672.

  41. Surwatana P, Meekhangvan J, Tamrongterakul T, Tanapat Y, Asavarait S, Boonjitrpimon P. Menopausal symptoms among Thai women in Bangkok. Maturitas 1991; 13: 317-28.

  42. Chaikittisilpa S, Limpaphayom K, Chompootweep S, Taechakraichana N. Symptoms and problems of menopausal women in Klong Toey slum. J Med Assoc Thai 1997; 80: 257-61.

  43. Sierra B, Hidalgo LA, Chedraui PA. Measuring climacteric symptoms in an Ecuadorian population with the Greene Climateric Scale. Maturitas 2005; 51: 236-45.

  44. Blumel JE, Brandt A, Tacla X. Symptomatic profile of the climacteric female clinical experience. Rev Med Chil 1992; 120: 1017-21.

  45. Pedro AO, Pinto-Neto AM, Costa-Paiva LH, Osis MJ, Ardí EE. Climacteric syndrome: a population-based study in Campinas, SP, Brazil. Rev Saude Publica 2003; 37: 735-42.

  46. Pearlstein T, Rosen K, Stone AB. Mood disorders and menopause. Endocrinol Metab Clin North Am 1997; 26: 279.

  47. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004; 61: 62-70.

  48. Avis NE, Brambilla D, McKilay SM, Vass K. A longitudinal analysis of the association between menopause and depression: results from the Massachusetts Women’s Health Study. Ann Epidemiol 1994; 4: 214-20.

  49. Blumel JEM, Castelo-Branco C, Cancelo MJ, Córdova AT, Binfa LE, Bonilla HG. Relationship between psychological complaints and vasomotor symptoms during climateric. Maturitas 2004; 49: 205-210.

  50. Huerta R, Mena A, Malacara JM, Diaz de León J. Symptoms at the menopausal and premenopausal years: their relationship with insulin, glucosa, cortisol, FSH, prolactin, obesity and attitudes towards sexuality. Psychoneuroendocrinology 1995; 20: 851-64.

  51. Kaufert, PA, Gilbert, P, Tate, R. The Manitoba Project: A re-examination of the link between menopause and depression. Maturitas 1992; 14: 143.

  52. Hunter MS. Psychological and somatic experience of the menopause: A prospective study. Psychosom Med 1990; 52: 357.

  53. Bromberg JT, Assmann SF, Avis NE, Schocken M, Kravitz HM, Cordal A. Persistent mood symptoms in a multiethnic community cohort of pre and perimenopausal women. Am J Epidemiol 2003; 258: 347-56.

  54. Harlow BL, Wise LA, Otto MW, Soares CN, Cohen LS. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with menopausal transition: the Harvard Study of moods and cycles. Arch Gen Psychiatry 2003; 60: 29-36.

  55. Huerta R, Mena A, Malacara JM, Diaz de León J. Symptoms at perimenopausal period and premenopausal years: its association with attitudes towards sexuality, life style, family function and FSH levels. Psychoneuroendocrinology 1995; 20: 135-48.

  56. Joffe H, Hall JE, Soares CN. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002; 9: 392-8.

  57. Jasienska G, Ziomkiewicz A, Górkiewicz M, Pajak A. Body mass, depressive symptoms and menopausal status: an examination of the “Jolly Fat” Hypothesis. Women’s Health Issues 2005; 15: 145-51.

  58. Notelovitz M. Estrogen therapy in management of problems associated with urogenital aging: a simple diagnostic test and the effect of the route of hormone administration. Maturitas 1995; 22(suppl): S31-S33.

  59. Pastore L, Carter R, Hulka B, Wells E. Self-reported urogenital symptoms in postmenopausal women: Women’s Health Initiative. The European Menopause Journal 2004; 49: 292-303.

  60. Burger HG, Dudley EC, Hooper JL. The endocrinology of the menopause transition: a cross-sectional study of a population-based simple. J Clin Encodrinol Metab 1995; 80: 3537-3545.

  61. Randoplh JF, Sowers M, Bondarenko IV. Change in estradiol and follicle stimulating hormone accross the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab 2004; 89: 1555.

  62. Santoro M, Lasley B, McConnell D. Body size and ethnicity are associated with menstrual cycle alterations in women en the early menopausal transition: the study of Women’s Health Across the nation (Swan) daily hormone Study. J Clin Endocrinol Metab 2004; 89: 2622-31.




2020     |     www.medigraphic.com